Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.39	96.69	54.04	54.82	73.54
Short-Term Investments	109.74	41.47	-	16.33	-
Cash & Short-Term Investments	118.12	138.16	54.04	71.14	73.54
Cash Growth	-14.50%	155.67%	-24.05%	-3.25%	88.84%
Accounts Receivable	-	0.77	0.23	0.92	0.33
Other Receivables	16.37	19.44	17.63	14.88	6.95
Total Trade Receivables	16.37	20.22	17.86	15.8	7.28
Other Current Assets	8.58	11.69	9.14	9.75	5.52
Total Current Assets	88.24	149.32	81.03	96.69	86.33
Net Property, Plant & Equipment	2.6	3.15	1.81	2.2	1.94
Other Intangible Assets	0.43	0.5	0.28	0.32	0.02
Goodwill	7.9	7.48	7.84	8.01	7.59
Long-Term Investments	-	0.28	-	0.28	0.3
Other Long-Term Assets	0.19	5.44	2.86	-	-
Total Assets	97.74	161.49	93.83	107.5	96.19
Accounts Payable	9.93	13.07	12.21	12.63	10.78
Current Portion of Leases	0.13	0.19	0.18	0.45	0.14
Unearned Revenue	0.12	0.24	5.16	8.86	4.25
Total Current Liabilities	10.12	13.41	17.55	21.94	15.17
Long-Term Leases	0.05	-	0.09	-	-
Other Long-Term Liabilities	41.24	41.27	58.92	-	-
Total Long-Term Liabilities	41.29	41.27	59.01	-	-
Total Liabilities	51.41	54.68	76.56	21.94	15.17
Common Stock	-14.74	-15.28	-6.95	5.39	4.49
Additional Paid-in Capital	-900.82	-921.3	-358.02	277.86	225.46
Accumulated Other Comprehensive Income	0.23	7.73	8.42	2.09	1.54
Retained Earnings	822.76	715.16	339.27	-263.26	-222.97
Total Common Shareholders' Equity	-92.57	-213.69	-17.28	22.07	8.53
Shareholders' Equity	46.24	106.88	-17.28	22.07	8.53
Total Liabilities & Equity	97.74	161.49	93.83	44.02	23.69
Total Debt	0.25	0.23	0.35	0.54	0.19
Net Cash (Debt)	158.6	173.13	68.44	85.53	99.24
Net Cash Growth	-8.39%	152.95%	-19.98%	-13.81%	88.04%
Net Cash Per Share	3.36	3.74	1.84	2.66	3.35
Book Value	-124.48	-268.14	-21.99	26.7	11.53
Book Value Per Share	-2.64	-5.80	-0.59	0.83	0.39
Tangible Book Value	-135.68	-278.16	-32.34	16.63	1.23
Tangible Book Value Per Share	-2.87	-6.01	-0.87	0.52	0.04

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q